TC BioPharm (TCBP) said Wednesday it will change its American Depositary Shares ratio, starting Monday to 1 ADS representing 4,000 ordinary shares, from 1 ADS representing 200 ordinary shares.
The ADS ratio change will act like a 1-for-20 reverse ADS split for ADS holders, without affecting the company's underlying ordinary shares or issuing or canceling any ordinary shares, the company said, adding that it will continue to be traded on Nasdaq Capital Market under the "TCBP" symbol.
The change requires ADS holders to exchange 20 ADSs for 1 new ADS, with fractional ADSs being aggregated and sold, and the net proceeds distributed to the applicable holders.
The ADS trading price is expected to increase proportionally, but the company cannot guarantee it will match or exceed the pre-change price, TC BioPharm said.
TC BioPharm shares were down 23% in recent trading.
Price: 0.28, Change: -0.08, Percent Change: -23.06
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。